Nausea Mechanisms in GLP-1 Therapy and Formulation Solutions
Targeting the brainstem can reduce nausea without sacrificing GLP-1's metabolic benefits.
Priya Subramaniam
Delivery Platform Review — Page 3
GLP-1 Therapeutics
Peptide Stability Challenges in GLP-1 Analog Formulation
Every stabilizing trick introduces new failure modes that complicate drug development elsewhere.
GLP-1 Injectable Dropout Rates and the Compliance Crisis
Most patients stop GLP-1 injections within a year, often before reaching effective doses.
Cecilia Brandt-Kowalski
More From Delivery Platform Review
Lipid Nanoparticles vs Polymeric Nanoparticles for Delivering Peptides to the CNS
Lipid nanoparticles excel at endosomal escape; polymeric ones protect peptides better in transit.
Marcus Oyelaran